TrialSignal transduction and targeted therapy2021

Effect of human umbilical cord-derived mesenchymal stem cells on lung damage in severe COVID-19 patients: a randomized, double-blind, placebo-controlled phase 2 trial.

Lei Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.